The expression of p-YB-1/PARP1 and the abemaciclib IC50 were positively correlated in seven breast cancer cell lines based on the quantitative analysis results of the protein level of p-YB-1/PARP1 and IC50 detection (Fig. 3B–C). This evidence concerns the gene PARP1 and breast carcinoma.